Karyopharm Therapeutics Inc. · NASDAQ:KPTI

T. Rowe Price Investment Management, Inc. reported a 6.60% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)

Event May 31, 2026 · Filed Jun 5, 2026

T. Rowe Price Investment Management, Inc. reported a 6.60% stake in Karyopharm Therapeutics Inc., 1,539,147 shares, as a passive investor on May 31, 2026. Filed Jun 5, 2026 (Schedule 13G/A).

Stake
6.60%
Shares
1,539,147
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.6.60%1,539,147

Source

View original at SEC

Related